PT1854826E - Polímeros de ligação a aniões e suas utilizações - Google Patents

Polímeros de ligação a aniões e suas utilizações Download PDF

Info

Publication number
PT1854826E
PT1854826E PT07109664T PT07109664T PT1854826E PT 1854826 E PT1854826 E PT 1854826E PT 07109664 T PT07109664 T PT 07109664T PT 07109664 T PT07109664 T PT 07109664T PT 1854826 E PT1854826 E PT 1854826E
Authority
PT
Portugal
Prior art keywords
anion
binding polymers
binding
cases
polymers
Prior art date
Application number
PT07109664T
Other languages
English (en)
Inventor
Dominique Charmot
Florence Roger
Gerrit Klaerner
Eric Connor
Ting Han Chang
Hoai Son Nguyen
Original Assignee
Ilypsa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/701,385 external-priority patent/US7385012B2/en
Priority claimed from US10/806,495 external-priority patent/US7335795B2/en
Application filed by Ilypsa Inc filed Critical Ilypsa Inc
Publication of PT1854826E publication Critical patent/PT1854826E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F26/06—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • C08G73/022—Preparatory process from polyamines and epihalohydrins
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/02—Homopolymers or copolymers of vinylamine
PT07109664T 2003-11-03 2004-11-03 Polímeros de ligação a aniões e suas utilizações PT1854826E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/701,385 US7385012B2 (en) 2003-11-03 2003-11-03 Polyamine polymers
US10/806,495 US7335795B2 (en) 2004-03-22 2004-03-22 Crosslinked amine polymers
US10/965,044 US7459502B2 (en) 2003-11-03 2004-10-13 Pharmaceutical compositions comprising crosslinked polyamine polymers

Publications (1)

Publication Number Publication Date
PT1854826E true PT1854826E (pt) 2008-12-15

Family

ID=34557428

Family Applications (3)

Application Number Title Priority Date Filing Date
PT08164715T PT2009042E (pt) 2003-11-03 2004-11-03 Polímeros de ligação a aniões e suas utilizações
PT07109664T PT1854826E (pt) 2003-11-03 2004-11-03 Polímeros de ligação a aniões e suas utilizações
PT04810316T PT1682606E (pt) 2003-11-03 2004-11-03 Polímeros de ligação a aniões e suas utilizações.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT08164715T PT2009042E (pt) 2003-11-03 2004-11-03 Polímeros de ligação a aniões e suas utilizações

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT04810316T PT1682606E (pt) 2003-11-03 2004-11-03 Polímeros de ligação a aniões e suas utilizações.

Country Status (18)

Country Link
US (1) US7459502B2 (pt)
EP (5) EP2009042B1 (pt)
JP (3) JP3996944B2 (pt)
KR (1) KR101052581B1 (pt)
AT (5) ATE546482T1 (pt)
AU (1) AU2004285609B2 (pt)
BR (1) BRPI0416172A (pt)
CA (1) CA2542730C (pt)
CY (3) CY1107728T1 (pt)
DE (5) DE602004023661D1 (pt)
DK (3) DK1854826T3 (pt)
ES (4) ES2287806T3 (pt)
GB (1) GB2426248B (pt)
HK (1) HK1101697A1 (pt)
PL (3) PL1854826T3 (pt)
PT (3) PT2009042E (pt)
SI (3) SI1854826T1 (pt)
WO (2) WO2005041902A2 (pt)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20060083791A1 (en) * 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US7381428B2 (en) 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
SG145765A1 (en) * 2003-08-26 2008-09-29 Shire Holdings Ag Pharmaceutical formulation comprising lanthanum compounds
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
WO2006044657A2 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
WO2007022445A2 (en) * 2005-08-17 2007-02-22 Altairnano, Inc. Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
ES2311443T1 (es) * 2005-08-17 2009-02-16 Altairnano, Inc Hiperfosfatemia en animales domesticos: composiciones y procedimientos de tratamiento.
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
US8114393B2 (en) * 2005-09-14 2012-02-14 Wisconsin Alumni Research Foundation Methods and compositions for phosphate binding
WO2007033269A1 (en) * 2005-09-14 2007-03-22 Wisconsin Alumni Research Foundation Composition comprising a dendrimer and the use thereof for binding phosphate
AU2012205214B2 (en) * 2005-09-15 2015-05-21 Genzyme Corporation Formulation for Amine Polymers
NZ566542A (en) * 2005-09-15 2011-06-30 Genzyme Corp Sachet formulation for amine polymers
CN101321519A (zh) * 2005-09-30 2008-12-10 伊立普萨公司 制备含有交联壳的核-壳型复合物的方法及其得到的核-壳型复合物
DE112006002618T5 (de) * 2005-09-30 2008-08-28 Ilypsa Inc., Santa Clara Verfahren und Zusammensetzungen zum selektiven Entfernen von Kaliumionen aus dem Gastrointestinaltrakt eines Säugers
CA2634160C (en) * 2006-01-05 2014-04-15 Lifecycle Pharma A/S Disintegrating loadable tablets
US20070177866A1 (en) * 2006-01-31 2007-08-02 Yoshizo Fujimoto Camera extension arm
US7749536B2 (en) * 2006-02-14 2010-07-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
CN100398112C (zh) * 2006-03-24 2008-07-02 辽宁诺康生物制药有限责任公司 一种治疗血磷酸盐过多症的药物及其制备方法
US20080085259A1 (en) * 2006-05-05 2008-04-10 Huval Chad C Amine condensation polymers as phosphate sequestrants
AU2007275711A1 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
EP2441779A1 (en) * 2006-09-01 2012-04-18 USV Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
WO2008042222A2 (en) 2006-09-29 2008-04-10 Genzyme Corporation Amide dendrimer compositions
EP2120972A1 (en) * 2006-12-14 2009-11-25 Genzyme Corporation Amido-amine polymer compositions
EP2114376A1 (en) * 2007-02-23 2009-11-11 Genzyme Corporation Amine polymer compositions
WO2008109095A1 (en) * 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
WO2008133954A1 (en) * 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
JPWO2009008480A1 (ja) * 2007-07-11 2010-09-09 東レ株式会社 架橋ポリアリルアミン又はその酸付加塩、及びその医薬用途
EP2016947A1 (en) * 2007-07-17 2009-01-21 Chemo Ibérica, S.A. Novel one step process for preparing cross-linked poly(allylamine) polymers
WO2009023544A2 (en) * 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
JP5332520B2 (ja) * 2007-11-07 2013-11-06 アステラス製薬株式会社 医薬用錠剤
WO2009097127A1 (en) * 2008-01-31 2009-08-06 Genzyme Corporation Pharmaceutical compositions
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
EP2389168A2 (en) * 2009-01-22 2011-11-30 USV Limited Pharmaceutical compositions comprising phosphate-binding polymer
IT1394299B1 (it) * 2009-05-12 2012-06-06 Chimico Internaz Spa Lab Procedimento per la preparazione di sevelamer
CN107266681A (zh) * 2010-02-24 2017-10-20 瑞立普萨公司 用作胆汁酸螯合剂的胺聚合物
WO2011106542A2 (en) * 2010-02-24 2011-09-01 Relypsa, Inc. Crosslinked polyvrnylamine, poly all ylamine, and polyethyleneimine for use as bile acid sequestrants
EP2538947B1 (en) * 2010-02-24 2016-08-17 Relypsa, Inc. Polyimidazoles for use as bile acid sequestrants
TWI446916B (zh) 2010-05-12 2014-08-01 Spectrum Pharmaceuticals Inc 鹼式碳酸鑭、碳酸氧鑭及其製備方法及用途
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9302922B2 (en) 2012-01-30 2016-04-05 California Institute Of Technology Filtration membranes and related compositions, methods and systems
US10369529B2 (en) 2012-01-30 2019-08-06 California Institute Of Technology Mixed matrix membranes with embedded polymeric particles and networks and related compositions, methods, and systems
EP2557074A1 (en) 2011-08-11 2013-02-13 Astellas Pharma Inc. Process for the preparation of N,N,N',N'-tetrakis(3-aminopropyl)-1,4-butanediamine
WO2014015121A1 (en) 2012-07-19 2014-01-23 Georgia-Pacific Chemicals Llc High efficiency wet strength resins from new cross-linkers
MX2015012843A (es) * 2013-03-15 2016-08-08 Genzyme Corp Agentes quelantes de precursores de producto final de glicacion avanzada (age).
PT3578185T (pt) 2013-06-05 2020-11-10 Tricida Inc Polímeros ligantes de protões para administração oral
US10435528B2 (en) 2013-09-17 2019-10-08 Aquanano Llc High-capacity anion exchange materials
JP5843986B2 (ja) * 2014-03-25 2016-01-13 アステラス製薬株式会社 粒状医薬組成物
WO2016043808A1 (en) 2014-09-17 2016-03-24 Aquanano Llc High-capacity anion exchange material
PL3593808T3 (pl) * 2014-12-10 2021-06-14 Tricida Inc. Polimery wiążące protony do podawania doustnego
WO2016164315A1 (en) * 2015-04-06 2016-10-13 3M Innovative Properties Company Removable film forming gel compositions and methods for their application
BR112017025566B1 (pt) * 2015-05-29 2022-11-29 Ecolab Usa Inc Resina de fortalecimento
US20190209607A1 (en) * 2016-05-06 2019-07-11 Tricida, Inc. Compositions for treating acid-base disorders
AU2017388956A1 (en) 2016-12-28 2019-07-11 Fujifilm Corporation Emulsion of nitrogen atom-containing polymer or salt thereof, production method therefor, and production method for particles
CN107141408A (zh) * 2017-06-12 2017-09-08 厦门建霖健康家居股份有限公司 一种抗菌聚合物及其制备方法
US10934380B1 (en) 2017-09-25 2021-03-02 Tricida, Inc. Crosslinked poly(allylamine) polymer pharmaceutical compositions
EP3698799B1 (en) * 2017-10-16 2022-01-26 FUJIFILM Corporation Hyperphosphatemia treatment agent
TW201922268A (zh) 2017-10-16 2019-06-16 日商富士軟片股份有限公司 高磷血症治療劑及粒子
EP3703706A4 (en) 2017-11-03 2022-04-27 Tricida Inc. COMPOSITIONS AND METHOD FOR TREATING ACID-BASE DISORDERS
CN111521705B (zh) * 2020-05-05 2021-04-20 大连润生康泰医学检验实验室有限公司 一种血清中胆汁酸的富集方法
WO2023064357A1 (en) * 2021-10-13 2023-04-20 Tricida, Inc. Pharmaceutical compositions for the treatment of lithiasis disorders
CN115260355A (zh) * 2022-05-16 2022-11-01 江苏中天药业有限公司 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US814789A (en) 1904-12-21 1906-03-13 Edward D Mackintosh Drawing and plotting device.
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
US3930810A (en) * 1974-07-31 1976-01-06 Universal Oil Products Company Additives for petroleum distillates
US4015939A (en) * 1976-05-12 1977-04-05 Bio-Rad Laboratories, Inc. Competitive binding thyroid assay with improved bound-free separation step
US4135880A (en) * 1977-08-19 1979-01-23 Bio-Rad Laboratories, Inc. Folate assay with ion exchange resin bound-free separation
US4410688A (en) * 1981-04-29 1983-10-18 Allied Corporation Macromolecular highly branched homogeneous compound
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4631337A (en) * 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
US4737550A (en) * 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4558120A (en) * 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4568737A (en) * 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
JPS6090243A (ja) * 1983-10-25 1985-05-21 Nitto Boseki Co Ltd 小球状モノアリルアミン橋かけ重合体の製造方法
US4587329A (en) * 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4599400A (en) * 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4734200A (en) * 1986-04-04 1988-03-29 Advanced Separation Technologies Incorporated Process for removal of fluoride and phosphorus-type contaminants from acidic wastewater
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5807582A (en) * 1988-08-26 1998-09-15 Pharmacia & Upjohn Company Fine-beaded colestipol hydrochloride and pharmaceutically elegant dosage forms made therefrom
GB8829088D0 (en) 1988-12-13 1989-01-25 Smith Kline French Lab Compounds
US5091175A (en) * 1990-05-14 1992-02-25 Erbamont Inc. Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
FR2680791B1 (fr) * 1991-08-30 1994-09-09 Bp Chemicals Snc Procede de fabrication d'un polymere reticule et utilisation du polymere.
BE1007260A3 (nl) 1993-07-08 1995-05-02 Dsm Nv Werkwijze voor het bereiden van een dendritisch macromolekuul.
US5530092A (en) * 1992-01-13 1996-06-25 Dsm N.V. Dendritic macromolecule and the preparation thereof
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
DE69410995T2 (de) * 1993-02-17 1998-11-05 British Tech Group 1 guanidino gruppen enthaltende polymere zur verwendung in der therapie
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5414068A (en) 1994-01-24 1995-05-09 Rohm And Haas Company Crosslinked anion exchange particles and method for producing the particles
EP0741756B1 (en) 1994-01-28 1998-04-22 Dsm N.V. Dendritic macromolecule and a process for the preparation thereof
BE1008134A3 (nl) 1994-03-16 1996-01-23 Dsm Nv Bereiding van stervormig vertakte polymeren.
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
GB9503061D0 (en) * 1995-02-16 1995-04-05 British Tech Group Polymeric compounds
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
NL1001973C2 (nl) * 1995-12-21 1997-06-24 Stork Friesland Bv Semipermeabel composietmembraan.
TW528597B (en) * 1996-03-05 2003-04-21 Mitsubishi Electric Corp Medicament for preventive and/or therapeutic treatment of hyperphosphatemia
US6034129A (en) * 1996-06-24 2000-03-07 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
KR20000067929A (ko) * 1996-07-19 2000-11-25 나가타 코이치 고인혈증 치료제
WO1998017707A1 (en) * 1996-10-23 1998-04-30 The Dow Chemical Company Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
JP2003183168A (ja) * 1997-04-04 2003-07-03 Chugai Pharmaceut Co Ltd リン酸結合性ポリマー含有製剤
US6423754B1 (en) * 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6007803A (en) * 1997-09-19 1999-12-28 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin binding agents
US20040170600A1 (en) * 1997-10-22 2004-09-02 Jaime Simon Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
US6726905B1 (en) * 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6566407B2 (en) * 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
HUP0100469A2 (hu) * 1997-12-19 2001-08-28 Smithkline Beecham Corporation Eljárás harapással diszpergálható tabletták előállítására
US6333051B1 (en) * 1998-09-03 2001-12-25 Supratek Pharma, Inc. Nanogel networks and biological agent compositions thereof
TW568788B (en) 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
JP3363143B2 (ja) * 1998-10-12 2003-01-08 中外製薬株式会社 リン酸結合性ポリマー粒子
US6361768B1 (en) * 1998-12-29 2002-03-26 Pmd Holdings Corp. Hydrophilic ampholytic polymer
US6180754B1 (en) * 1999-09-03 2001-01-30 The Dow Chemical Company Process for producing cross-linked polyallylamine polymer
US6362266B1 (en) * 1999-09-03 2002-03-26 The Dow Chemical Company Process for reducing cohesiveness of polyallylamine polymer gels during drying
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
WO2001066607A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
DE10011481A1 (de) * 2000-03-09 2001-10-18 Fresenius Hemocare Gmbh Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Verwendung des Adsorbens zur Herstellung eines Adsorbers und Adsorber mit dem Adsorbens
AU2001241076A1 (en) * 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
AU2001241095A1 (en) * 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
US6471968B1 (en) * 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
GB2374072B (en) * 2000-06-16 2004-09-22 Nippon Catalytic Chem Ind Crosslinked polymer method for manufacturing it and use thereof
AU2002232955A1 (en) * 2000-11-20 2002-05-27 Dow Global Technologies Inc. In vivo use of water absorbent polymers
US6710162B2 (en) * 2001-02-16 2004-03-23 Genzyme Corporation Method of drying a material having a cohesive phase
CA2444046C (en) * 2001-04-18 2011-06-07 Steven K. Burke Use of colesevelam in reducing serum glucose
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
CN1509180A (zh) * 2001-04-18 2004-06-30 ԭ���ø� 用脂肪族聚胺治疗综合症x的方法
WO2002085383A1 (en) * 2001-04-18 2002-10-31 Genzyme Corporation Method for reducing copper levels and treating copper toxicosis
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
EP1416942B1 (en) * 2001-04-18 2007-12-12 Genzyme Corporation Amine polymers for treating gout and binding uric acid
US6600011B2 (en) * 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
JP3931639B2 (ja) * 2001-11-19 2007-06-20 セイコーエプソン株式会社 インクジェットプリンタに使用するための水性インク組成物
WO2004037274A1 (en) * 2002-10-22 2004-05-06 Genzyme Corporation Amine polymers for promoting bone formation
DE10305807A1 (de) 2003-02-12 2004-08-26 Basf Ag Polymethylenamine und Verfahren zu deren Herstellung
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US20050276781A1 (en) * 2004-06-09 2005-12-15 Ross Edward A Molecularly imprinted phosphate binders for therapeutic use

Also Published As

Publication number Publication date
ES2330693T3 (es) 2009-12-14
ATE364057T1 (de) 2007-06-15
DE602004006892D1 (de) 2007-07-19
CY1110562T1 (el) 2015-04-29
ES2308294T3 (es) 2008-12-01
KR101052581B1 (ko) 2011-07-29
EP1682606A2 (en) 2006-07-26
WO2005041900A2 (en) 2005-05-12
WO2005041902A2 (en) 2005-05-12
KR20070026338A (ko) 2007-03-08
US7459502B2 (en) 2008-12-02
DE112004002099T5 (de) 2007-01-04
HK1101697A1 (en) 2007-10-26
CA2542730C (en) 2012-07-10
DE602004017918D1 (de) 2009-01-02
CY1107728T1 (el) 2013-04-18
SI1854826T1 (sl) 2009-06-30
AU2004285609A1 (en) 2005-05-12
DE602004014527D1 (de) 2008-07-31
EP1834976B1 (en) 2012-02-22
BRPI0416172A (pt) 2007-01-16
DE602004023661D1 (de) 2009-11-26
EP1687349B1 (en) 2008-06-18
JP3996944B2 (ja) 2007-10-24
GB0610607D0 (en) 2006-07-05
PT1682606E (pt) 2007-09-05
PT2009042E (pt) 2009-10-23
EP1834976A1 (en) 2007-09-19
ES2318823T3 (es) 2009-05-01
GB2426248A (en) 2006-11-22
ES2287806T3 (es) 2007-12-16
AU2004285609B2 (en) 2009-04-23
ATE445662T1 (de) 2009-10-15
WO2005041902A3 (en) 2006-05-18
DK1682606T3 (da) 2007-10-01
EP1682606A4 (en) 2006-12-20
DE602004006892T2 (de) 2008-02-07
EP1854826B1 (en) 2008-11-19
GB2426248B (en) 2008-08-13
ATE414730T1 (de) 2008-12-15
EP1682606B1 (en) 2007-06-06
DK2009042T3 (da) 2009-11-30
EP1687349A4 (en) 2006-12-27
US20050131138A1 (en) 2005-06-16
CA2542730A1 (en) 2005-05-12
JP5074838B2 (ja) 2012-11-14
JP4902864B2 (ja) 2012-03-21
PL2009042T3 (pl) 2010-05-31
JP2007262421A (ja) 2007-10-11
PL1854826T3 (pl) 2009-06-30
EP1687349A2 (en) 2006-08-09
EP2009042B1 (en) 2009-10-14
ATE398636T1 (de) 2008-07-15
ATE546482T1 (de) 2012-03-15
JP2007510783A (ja) 2007-04-26
EP2009042A1 (en) 2008-12-31
SI2009042T1 (sl) 2009-12-31
CY1110475T1 (el) 2015-04-29
PL1682606T3 (pl) 2007-10-31
WO2005041900A3 (en) 2006-06-08
EP1854826A1 (en) 2007-11-14
SI1682606T1 (sl) 2007-10-31
DK1854826T3 (da) 2009-01-12
JP2007146180A (ja) 2007-06-14

Similar Documents

Publication Publication Date Title
GB2426248B (en) Anion-binding polymers and uses thereof
ATE478835T1 (de) Feststoffhaltige, wasserquellende und -saugende, anionische polymere mit schwammstruktur sowie deren herstellung und verwendung
AU2003300140A1 (en) Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
NO20076284L (no) Vannsvellbart hybridmateriale med uorganiske tilsetningsstoffer, og fremgangsmate for fremstilling av dette
NO20074331L (no) Kromatografiske medier
El‐Hag Ali Removal of heavy metals from model wastewater by using carboxymehyl cellulose/2‐acrylamido‐2‐methyl propane sulfonic acid hydrogels
ATE533791T1 (de) Mit einer polymerisierbaren gruppierung funktionalisiertes hydrogel und anwendungen davon als biosensoren oder bioreaktoren
WO2008021631A8 (en) Polymeric gel composition and method for making
ATE239759T1 (de) Verfahren zur herstellung stabilisierter, feindisperser und niedrigviskoser polymerpolyole mit hohen gehalt an styrol oder styrol- copolymerisaten
WO2005030820A3 (de) Hydrogel
WO2008015653A3 (en) Polymeric viscosity modifiers
Vega et al. Optimizing chemical conditioning for odour removal of undigested sewage sludge in drying processes
ATE431971T1 (de) Festpolymerelektrolytmenbran und brennstofzelle
ATE302218T1 (de) Mischpolymere zur optischen datenspeicherung
Dehli et al. Gelatin-Based Foamed and Non-foamed Hydrogels for Sorption and Controlled Release of Metoprolol
Hegger et al. Charge matters: modulating secondary interactions in hyaluronan hydrogels
WO2006047157A3 (en) Novel compositions of monomers, oligomers and polymers and methods for making the same
WO2007012850A3 (en) Denture support composition
WO2003087764A3 (en) Connection of cells to substrates using association pairs